Hydra Raises $22 Million in Funding Round

Hydra Biosciences Inc., a Cambridge biotechnology company that is developing novel ion channel drugs, is set to disclose that it has raised $22.2 million in venture capital in a financing round led by MedImmune Ventures of Gaithersburg, Md.
boston.com